Position in BNTX
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$3,110,800
+$540,400 QoQ
Shares Held
35,000
+29.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Raiffeisen Bank International AG holds $97,826,369 across 28 Biotechnology names. BNTX ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101,435 | $45,294,784 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,203 | $17,927,565 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,413 | $3,445,349 | |
| 4 | BNTX |
BioNTech SE
This page
|
35,000 | $3,110,800 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
36,000 | $2,703,240 | |
| 6 | LEGN |
Legend Biotech Corp
|
140,000 | $2,532,600 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
26,000 | $2,528,500 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
190,000 | $1,890,500 |
All Filings in BNTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,110,800 | 35,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,570,400 | 27,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,577,920 | 16,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,117,935 | 10,500 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $910,600 | 10,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,139,500 | 10,000 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||